All translations

Enter a message name below to show all available translations.

Found 2 translations.

Name	Current message text
^h English (en)	==Side effects== The most common side effects include gastrointestinal disorders, such as [[dyspepsia]], [[decreased appetite]], [[nausea]], [[vomiting]], [[abdominal pain]], [[diarrhea]]. Some patients may experience serious adverse reactions: [[acute pancreatitis]] (symptoms include persistent severe abdominal pain, sometimes radiating to the back and accompanied by vomiting), [[hypoglycemia]], [[renal impairment]] (which may sometimes require hemodialysis). The risk of hypoglycemia is increased if the drug is used in combination with [[sulfonylurea]]s or [[insulin]]. There is also a potential risk of [[medullary thyroid carcinoma]] associated with the use of the drug.
^h Japanese (ja)	==副作用== {{Anchor\|Side effects}} 最も一般的な副作用は、[[dyspepsia/ja\|消化不良]]、[[decreased appetite/ja\|食欲減退]]、[[nausea/ja\|吐き気]]、[[vomiting/ja\|嘔吐]]、[[abdominal pain/ja\|腹痛]]、[[diarrhea/ja\|下痢]]などの胃腸障害である。重篤な副作用を経験する患者もいる： [[acute pancreatitis/ja\|急性膵炎]]（症状には持続性の激しい腹痛が含まれ、時に背中に放散し、嘔吐を伴う）、[[hypoglycemia/ja\|低血糖症]]、[[renal impairment/ja\|腎障害]]（時に血液透析を必要とすることがある）。低血糖のリスクは、薬物を[[sulfonylurea/ja\|スルホニルウレア]]または[[insulin/ja\|インスリン]]と併用した場合に増大する。薬物の使用に関連した[[medullary thyroid carcinoma/ja\|甲状腺髄様がん]]の潜在的リスクもある。